Seibu Mochizuki – författare

In an attempt to clarify the situation regarding the diagnosis, pathogenesis and therapeutics of cardiovascular dysfunction in diabetes, an International Symposium on Diabetic Heart was held in Tokyo, Japan during October, 1989. 32 selected articles from the poster presentations, compiled in this book, have been grouped in four sections: evaluation of cardiovascular problems, interactions of diabetes and hypertension, pathophysiological aspects of cardiovascular dysfunction in diabetes and pharmacological and therapeutic aspects of diabetic heart. It is hoped that the contents of these chapters will provide adequate information regarding the current status of cardiovascular abnormalities in diabetes and this book should be of interest to both clinical and experimental cardiologists as well as endocrinologists interested in diabetes.

A variety of metabolic processes are known to be intimately involved in the maintenance of cellular structure and function. lt has also become clear that metabolic events involved in the synthesis and hydrolysis of ATP as well as for the synthesis of proteins and phospholipids are essential for cellular health. The regulation of cell function is generally achieved through participation of a wide variety of hormones and different signal transduction mechanisms for the activation/deactivation of some specific metabolic processes. In this regard cyclic AMP and calcium seem to play a crucial role. Various hormones are also known to affect the genetic machinery of all the cell; however, the exact signals for genetic control of cellular function are not well defined. In particular, the sequence of events concerned with remodelling of different types of cells under various pathological situations is poorly understood. In this book we have therefore dealt with some of these issues from biochemical, molecular biological, physiological, and pharmacological viewpoints.Special emphasis has been laid on understanding heart function and metabolism in health and disease in general, and cardiac hypertrophy, heartfailure, and ischemic heartdisease in particular. It is hoped that this multidisciplinary information will be of value to basic scientists and clinical investigators.

The last three decades of the 20th century saw impressive progress in the field of pathogenesis, prevention and therapy of ischemic heart disease which resulted in a marked decline in mortality in the Western World. However, the incidence of this devastating disease is on the rise in developing countries. This volume is organized into two sections: pathophysiologic mechanisms of ischemia-reperfusion injury; and preconditioning and protection of ischemia-reperfusion injury it contains late-1990s information concerning the current concepts of ischemia-reperfusion injury, the sequence of events resulting in the loss of contractile dysfunction, and mechanisms of cardioprotection by several drugs as well as the role of ischemic preconditioning in attenuating problems associated with ischemia-reperfusion injury.

A variety of metabolic processes are known to be intimately involved in the maintenance of cellular structure and function. It has also become clear that metabolic events involved in the synthesis and hydrolysis of ATP as well as for the synthesis of proteins and phospholipids are essential for cellular health. The regulation of cell function is generally achieved through participation of a wide variety of hormones and different signal transduction mechanisms for the activation/deactivation of some specific metabolic processes. In this regard cyclic AMP and calcium seem to play a crucial role. Various hormones are also known to affect the genetic machinery of all the cell; however, the exact signals for genetic control of cellular function are not well defined. In particular, the sequence of events concerned with remodelling of different types of cells under various pathological situations is poorly understood. In this book we have therefore dealt with some of these issues from biochemical, molecular biological, physiological, and pharmacological viewpoints. Special emphasis has been laid on understanding heart function and metabolism in health and disease in general, and cardiac hypertrophy, heart failure, and ischemic heart disease in particular. It is hoped that this multidisciplinary information will be of value to basic scientists and clinical investigators.

In an attempt to clarify the situation regarding the diagnosis, pathogenesis and therapeutics of cardiovascular dysfunction in diabetes, an International Symposium on Diabetic Heart was held in Tokyo, Japan during October, 1989.